Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
International Journal of Molecular Sciences
|
July 24, 2021
Adenosine and Inflammation: Here, There and Everywhere
Silvia Pasquini, Chiara Contri, Pier Andrea Borea, et al.
Frontiers in Pharmacology
|
October 24, 2022
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications
Silvia Pasquini, Chiara Contri, Martina Cappello, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets
Silvia Pasquini, Chiara Contri, Stefania Merighi, et al.
Cells
|
February 15, 2022
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Biomolecules
|
June 28, 2023
Caffeine for Prevention of Alzheimer's Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target?
Stefania Merighi, Alessia Travagli, Manuela Nigro, et al.
Biomolecules
|
September 28, 2023
Pharmacology of Adenosine Receptors: Recent Advancements
Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri, et al.
Journal of Pineal Research
|
April 12, 2024
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence
Annalida Bedini, Gian Marco Elisi, Fabiola Fanini, et al.
Archiv Der Pharmazie
|
September 26, 2023
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents
Alessandro Papa, Ilaria Cursaro, Luca Pozzetti, et al.
Chemmedchem
|
October 4, 2022
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells
Gabriele Carullo, Laura Bottoni, Silvia Pasquini, et al.
European Journal of Medicinal Chemistry
|
December 3, 2022
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions
Alessandro Papa, Silvia Pasquini, Francesca Galvani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
International Journal of Molecular Sciences
|
July 24, 2021
Adenosine and Inflammation: Here, There and Everywhere
Silvia Pasquini, Chiara Contri, Pier Andrea Borea, et al.
Frontiers in Pharmacology
|
October 24, 2022
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications
Silvia Pasquini, Chiara Contri, Martina Cappello, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets
Silvia Pasquini, Chiara Contri, Stefania Merighi, et al.
Cells
|
February 15, 2022
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Biomolecules
|
June 28, 2023
Caffeine for Prevention of Alzheimer's Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target?
Stefania Merighi, Alessia Travagli, Manuela Nigro, et al.
Biomolecules
|
September 28, 2023
Pharmacology of Adenosine Receptors: Recent Advancements
Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri, et al.
Journal of Pineal Research
|
April 12, 2024
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence
Annalida Bedini, Gian Marco Elisi, Fabiola Fanini, et al.
Archiv Der Pharmazie
|
September 26, 2023
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents
Alessandro Papa, Ilaria Cursaro, Luca Pozzetti, et al.
Chemmedchem
|
October 4, 2022
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells
Gabriele Carullo, Laura Bottoni, Silvia Pasquini, et al.
European Journal of Medicinal Chemistry
|
December 3, 2022
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions
Alessandro Papa, Silvia Pasquini, Francesca Galvani, et al.
Page
of 2